AZIDUS BRASIL PESQUISA CIENTIFICA E DESENVOLVIMENTO LTDA

🇧🇷Brazil

Country: 🇧🇷Brazil

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Pharmacokinetics and Pharmacodynamics of Interferon Alpha 2A

Completed

Conditions: Healthy

Interventions: Biological: Interferon alpha 2a

First Posted Date: 2010-10-26

Last Posted Date: 2010-10-26

Lead Sponsor: Azidus Brasil

Target Recruit Count: 24

Registration Number: NCT01228422

Locations: 🇧🇷
Lal Clinica Pesquisa E Desenvolvimento Ltda, Valinhos, Sao Paulo, Brazil

Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate

Phase 2

Suspended

Conditions: Plaque Psoriasis

Interventions: Drug: mometasone furoate + salicylic acid
Drug: Mometasone furoate

First Posted Date: 2010-10-26

Last Posted Date: 2022-11-03

Lead Sponsor: Azidus Brasil

Target Recruit Count: 40

Registration Number: NCT01228656

Study for Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals (Natugerin®) in Improvement of Stress and Fatigue

Phase 3

Conditions: Stress
Fatigue

Interventions: Dietary Supplement: NatusGerin
Other: Placebo capsules

First Posted Date: 2010-10-25

Last Posted Date: 2010-10-25

Lead Sponsor: Azidus Brasil

Target Recruit Count: 300

Registration Number: NCT01228006

Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis

Phase 3

Conditions: Acute Bacterial Conjunctivitis

Interventions: Drug: Tobracort
Drug: Tobradex

First Posted Date: 2010-10-25

Last Posted Date: 2010-10-25

Lead Sponsor: Azidus Brasil

Target Recruit Count: 70

Registration Number: NCT01227915

Locations: 🇧🇷
LAL Clínica Pesquisa e Desenvolvimento Ltda, Valinhos, São Paulo, Brazil

Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis

Phase 3

Conditions: Bacterial Conjunctivitis
Acute

Interventions: Drug: MAXINOM®
Drug: Maxitrol®

First Posted Date: 2010-10-25

Last Posted Date: 2010-10-25

Lead Sponsor: Azidus Brasil

Target Recruit Count: 70

Registration Number: NCT01227863

Locations: 🇧🇷
LAL Clinica Pesquisa e Desenvolvimento Ltda, Valinhos, São Paulo, Brazil

Clinical Efficacy of the Drug Ster® Compared With Predfort® in Control of Postoperative Inflammation in Cataract Surgery

Phase 3

Completed

Conditions: Inflammation
Cataract Surgery

Interventions: Drug: Ster
Drug: Pred Fort

First Posted Date: 2010-10-25

Last Posted Date: 2022-11-02

Lead Sponsor: Azidus Brasil

Target Recruit Count: 106

Registration Number: NCT01227876

Locations: 🇧🇷
LAL Clínica Pesquisa e Desenvolvimento Ltda, Valinhos, São Paulo, Brazil

Efficacy and Safety of a New Botulinum Toxin Type A for Treatment of Facial Expression Lines

Phase 3

Completed

Conditions: Wrinkles

Interventions: Drug: Botulift
Drug: Botox

First Posted Date: 2010-08-12

Last Posted Date: 2016-03-04

Lead Sponsor: Azidus Brasil

Target Recruit Count: 192

Registration Number: NCT01180348

Locations: 🇧🇷
LAL Clinica Pesquisa e Desenvolvimento Ltda, Valinhos, Sao Paulo, Brazil

Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis

Phase 3

Withdrawn

Conditions: Dermatitis

Interventions: Drug: dexamethasone 0.5 mg and 1.0 mg clemastine cream
Drug: Dexamethasone 0,5 mg cream

First Posted Date: 2010-05-18

Last Posted Date: 2022-11-03

Lead Sponsor: Azidus Brasil

Registration Number: NCT01125761

Locations: 🇧🇷
LAL Clínica Pesquisa e Desenvolvimento Ltda, Valinhos, São Paulo, Brazil
🇧🇷
LAL Clinica Pesquisa e Desenvolvimento Ltda, Valinhos, São Paulo, Brazil

Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin

Phase 3

Conditions: Cough

Interventions: Drug: Guaiacol, eucalyptol, menthol and camphor suppository
Drug: guaiacol suppository
Drug: Guaifenesin syrup

First Posted Date: 2010-05-07

Last Posted Date: 2011-01-28

Lead Sponsor: Azidus Brasil

Target Recruit Count: 270

Registration Number: NCT01119534

Locations: 🇧🇷
LAL Clínica Pesquisa e Desenvolvimento Ltda, Valinhos, SP, Brazil

Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI)

Phase 3

Conditions: Venous Insufficiency

Interventions: Drug: Flavonid
Drug: Daflon

First Posted Date: 2010-04-26

Last Posted Date: 2010-10-27

Lead Sponsor: Azidus Brasil

Target Recruit Count: 140

Registration Number: NCT01110512

Locations: 🇧🇷
Lal Clínica Pesquisa e Desenvolvimento Ltda, Valinhos, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy